Long noncoding RNA KCNQ1OT1 induces pyroptosis in diabetic corneal endothelial keratopathy
Diabetic corneal endothelial keratopathy is an intractable ocular complication which seriously threaten vision. It has been suggested that diabetes is associated with pyroptosis, a type of inflammatory programmed cell death. Long noncoding RNA KCNQ1OT1 is involved in pathophysiological mechanisms of diabetic complications, including diabetic cardiomyopathy and diabetic retinopathy. The aim of this study was to investigate the mechanisms of KCNQ1OT1 in diabetic corneal endothelial keratopathy. Here, we reveal that KCNQ1OT1 and pyroptosis can be triggered in diabetic human and rats corneal endothelium, along with the high glucose-treated corneal endothelial cells. However, miR-214 expression was substantially decreased in vivo and in experiments with cultured cells. LDH assay verified pyroptosis in high glucose-treated cells. Bioinformatics prediction and luciferase assays showed that KCNQ1OT1 may bind miR-214 to regulate the expression of caspase-1. We further transfectec miR-214 mimic and inhibitor into the high glucose-treated corneal endothelial cells. The results showed that upregulation of miR-214 attenuated pyroptosis; conversely, knockdown of miR-214 promoted it. In addition, KCNQ1OT1 knockdown by a small interfering RNA decreased pyroptosis factors expressions, but enhanced miR-214 expression. To understand the mechanisms underlying the pre-pyroptotic properties of KCNQ1OT1, si-KCNQ1OT1 was co-transfected with or without miR-214 inhibitor. The results showed that pyroptosis was repressed after silencing KCNQ1OT1, but was reversed by co-transfection with miR-214 inhibitor, suggesting that KCNQ1OT1 mediated pyroptosis induced by high glucose via targeting miR-214. Therefore, the KCNQ1OT1/miR-214/caspase-1 signaling pathway represents a new mechanism of diabetic corneal endothelial keratopathy, and KCNQ1OT1 could potentially be a novel therapeutic target.